| Literature DB >> 9694322 |
J Sizun1, N Arbour, P J Talbot.
Abstract
Human coronaviruses, with two known serogroups named 229E and OC43, cause up to one third of common colds and may be associated with serious diseases such as nosocomial respiratory infections, enterocolitis, pericarditis and neurological disorders. Reliable methods of detection in clinical samples are needed for a better understanding of their role in pathology. As a first step in the design of such diagnostic procedures, the sensitivities and specificities of two viral diagnostic assays were compared in an experimental cell culture model: an indirect immuno-fluorescence assay using monoclonal antibodies and reverse transcriptase-polymerase chain reaction amplification of viral RNA from infected cells. Immunofluorescence detected human coronaviruses in cells infected at a MOI as low as 10(-2) (log TCID50/ml = 4.25 for HCV-229E and 2.0 for HCV-OC43; log PFU/ml = 4.83 for HCV-229E and 1.84 for HCV-OC43) versus 10(-3) (HCV-OC43) or 10(-4) (HCV-229E) for reverse transcriptase-polymerase chain reaction amplification (log TCID50/ml = 1.75 for HCV-229E and 1.5 for HCV-OC43; log PFU/ml = 2.3 for HCV-229E and 1.34 for HCV-OC43). There were no false positive signals with other human respiratory pathogens: influenza virus, respiratory syncytial virus and adenovirus. Moreover, each assay was coronavirus serogroup-specific. These results demonstrate the potential usefulness of immunofluorescence with monoclonal antibodies and reverse transcriptase-polymerase chain reaction RNA amplification for the rapid detection of human coronaviruses in infected cell cultures. Both methods could be applied to clinical specimens for the diagnosis of human infections.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9694322 PMCID: PMC7119642 DOI: 10.1016/s0166-0934(98)00013-5
Source DB: PubMed Journal: J Virol Methods ISSN: 0166-0934 Impact factor: 2.014
Primers for RT-PCR amplification of HCV RNA
| HCV | Primers |
|---|---|
| 229E | 5′-TCTGCCAAGAGTCTTGCTCG-3′ (E7, sense) |
| 5′-AGCATAGCAGCTGTTGACGG-3′ (E9, antisense) | |
| OC43b | 5′-CCCAAGCAAACTGCTACCTCTCAG-3′ (O1, sense) |
| 5′-GTAGACTCCGTCAATATCGGTGCC-3′ (O3, antisense) |
Amplified region corresponding to nucleotides 819–1054 of the nucleocapsid protein gene (Schreiber et al., 1989, Bonavia et al., 1997).
bAmplified region corresponding to nucleotides 215–520 of the nucleocapsid protein gene (Kamahora et al., 1989, Stewart et al., 1992).
Detection of human coronaviruses in cell culture by IF and RT-PCR
| HCV | MOI | Infectious viral titer (log TICD50/ml) | IF mAb 5–11H.6 | IF mAb 1–10C.1 | RT-PCR primers E7–E9 | RT-PCR primers O1–O3 |
|---|---|---|---|---|---|---|
| 229E | 1 | 4.0 | + | − | + | − |
| 10−1 | 4.75 | + | − | + | − | |
| 10−2 | 4.25 | + | − | + | − | |
| 10−3 | 2.75 | − | − | + | − | |
| 10−4 | 1.75 | − | − | + | − | |
| 10−5 | <0.5 | − | − | − | − | |
| OC43 | 10−1 | 3.0 | − | + | − | + |
| 10−2 | 2.0 | − | + | − | + | |
| 10−3 | 1.5 | − | − | − | + | |
| 10−4 | <0.5 | − | − | − | − | |
| 10−5 | <0.5 | − | − | − | − |
Susceptible cells were infected at the indicated MOI to yield virus preparations with the indicated infectious viral titers measured by an immunoperoxidase assay. These viral preparations were used for IF using mAbs 5–10H.6 (229E-specific) or 1–10C.1 (OC43-specific) or RT-PCR with primer pairs E7–E9 (229E-specific) or O1–O3 (OC43-specific).
Fig. 1Results of RT-PCR detection of human coronaviruses. Panel A: RT-PCR for HCV-OC43: lanes 1–5, HRT-18 cells infected with logarithmic dilutions of HCV-OC43 (log TCID50/ml=3.0, 2.0, 1.5, <0.5, <0.5, respectively); lanes 6–8, cells infected with either human respiratory syncytial virus, influenza virus or adenovirus, respectively; lane 9, positive control with HCV-OC43 RNA; lane 10, L-132 cells infected with HCV-229E; lanes 11 and 12, negative controls (RT and PCR, respectively). Panel B: RT-PCR for HCV-229E; lanes 1–5, L-132 cells infected with logarithmic dilutions of HCV-229E (log TCID50/ml=4.75, 4.25, 2.75, 1.75, <0.5, respectively); lanes 6–8, cells infected with either human respiratory syncytial virus, influenza virus or adenovirus, respectively; lane 9: positive control with HCV-229E RNA; lane 10: HRT-18 cells infected with HCV-OC43, lanes 11 and 12, negative controls (RT and PCR, respectively).
Fig. 2Detection of human coronaviral antigens by indirect immunofluorescence on infected cells. Panels A and B: HRT-18 cells infected with HCV-OC43; Panels C and D: L132 cells infected with HCV-229E. Immunodetection was achieved with mAbs to either HCV-229E (5–11H.6: panels A and C), or HCV-OC43 (1–10C.1: panels B and D). Magnification: ×1200.